Get the latest Science News and Discoveries

World-first study into precision medicine for high-risk childhood cancer yields extraordinary results - EurekAlert


In a world-first, Australian researchers and clinicians have shown that precision medicine leads to significantly improved outcomes in children with high risk cancer. In a study published in Nature Medicine, the researchers found that precision medicine (also called personalized medicine) was shown to be superior to standard or non-guided therapy, both in terms of clinical response and survival - with a staggering 55% of children who received their personalised treatment achieved complete or partial remission, or had their disease stabilised for at least 6 months.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Study

Study

Photo of Precision Medicine

Precision Medicine

Photo of EurekAlert

EurekAlert

Related news:

News photo

'Artificial lymph node' used to treat cancer in mice - EurekAlert

News photo

Life-changing impact - EurekAlert

News photo

Molecular pathway that impacts pancreatic cancer progression and response to treatment detailed - EurekAlert